Related Experiment Video
Updated: Mar 29, 2026
13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
40.1K
Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic Studies
Annalisa Lonetti1, Maria Chiara Fontana2, Giovanni Martinelli2
1Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Methods in Molecular Biology (Clifton, N.J.)
|November 29, 2015
Summary
Genetic variations impact drug response. The Drug Metabolizing Enzymes and Transporters (DMET) assay genotypes genes for absorption, distribution, metabolism, and excretion, guiding personalized therapies and minimizing side effects.
Area of Science:
- Pharmacogenomics
- Clinical Chemistry
Background:
- Genetic variations significantly influence individual drug efficacy and the potential for adverse drug reactions.
- Understanding these variations is crucial for optimizing patient treatment outcomes.
Purpose of the Study:
- To introduce the Drug Metabolizing Enzymes and Transporters (DMET) assay as a tool for analyzing genetic determinants of drug response.
- To highlight the utility of DMET assay in clinical applications for personalized medicine.
Main Methods:
- Utilized Affymetrix's high-throughput DMET assay technology.
- Simultaneously genotyped multiple gene variants critical for drug ADME (Absorption, Distribution, Metabolism, Excretion).
Main Results:
- The DMET assay provides a comprehensive genetic map of drug-related genes.
- Enabled simultaneous analysis of numerous variants impacting drug pharmacokinetics and pharmacodynamics.
Conclusions:
- The DMET assay facilitates precise genetic profiling to guide therapeutic strategies.
- This technology aids in avoiding adverse drug effects and improving treatment efficacy through personalized genetic insights.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
01:27Principles of Pharmacogenetics: Types of Genetic Variants
95
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
95
01:27Pharmacogenetics of Drug Metabolism: Overview
112
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
112
01:29Pharmacogenetics and Pharmacogenomics: Overview
144
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
144
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
109
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
01:05Single Nucleotide Polymorphisms-SNPs
19.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.8K